| |
| |
|
| Insider
Information: |
Cavazza Paolo |
| Relationship: |
10% Owner |
| City: |
Lugano |
| State: |
V8 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
10,656,982 |
|
|
Indirect Shares
|
18,340,916 |
|
|
| Direct
Value |
$476,546 |
|
|
|
Indirect Value
|
$1,328,416 |
|
|
| Total
Shares |
28,997,898 |
|
|
| Total
Value |
$1,804,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -31.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
10% Owner |
2008-01-30 |
822,815 |
2008-01-30 |
8,635,831 |
Premium* |
|
|
Questcor Pharmaceuticals Inc |
QCOR |
10% Owner |
2005-04-15 |
8,643,397 |
2005-04-15 |
4,922,156 |
Premium* |
|
|
Regenerx Biopharmaceuticals Inc |
RGN |
10% Owner |
|
0 |
2021-06-30 |
1,500,000 |
Premium* |
|
|
Soligenix Inc Common |
SNGX |
10% Owner |
2010-06-18 |
1,190,770 |
2010-06-18 |
3,282,929 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2003-06-11 |
4 |
B |
$0.63 |
$2,000,000 |
I/I |
3,184,713 |
7,440,032 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2004-01-23 |
4 |
B |
$0.95 |
$1,000,000 |
I/I |
1,052,632 |
8,492,664 |
1.5 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2004-09-03 |
4 |
OE |
$1.09 |
$1,499,999 |
I/I |
1,382,488 |
9,875,152 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2004-12-09 |
4 |
B |
$5.00 |
$12,500 |
I/I |
2,500 |
2,929,872 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2004-12-17 |
4 |
B |
$0.00 |
$202,500 |
I/I |
40,500 |
2,500 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2004-12-17 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
457,815 |
2.37 |
- |
|
| RGN |
Regenerx Biopharmaceutica... |
10% Owner |
– – • |
2005-01-07 |
4 |
B |
$3.25 |
$3,199,999 |
I/I |
984,615 |
984,615 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-01-28 |
4 |
OE |
$7.50 |
$54,750 |
D/D |
7,300 |
465,115 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-01-31 |
4 |
B |
$0.00 |
$60,000 |
I/I |
20,000 |
2,500 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-03 |
4 |
B |
$3.23 |
$64,520 |
I/I |
20,000 |
22,500 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-04 |
4 |
B |
$3.30 |
$40,242 |
I/I |
12,197 |
34,697 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-07 |
4 |
B |
$0.00 |
$68,394 |
I/I |
19,501 |
501,069 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-07 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
501,069 |
1.42 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-07 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
465,115 |
2.37 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-10 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
465,115 |
2.37 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-10 |
4 |
B |
$0.00 |
$68,000 |
I/I |
20,000 |
501,069 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-14 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
74,198 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-14 |
4 |
OE |
$7.50 |
$27,750 |
D/D |
3,700 |
468,815 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-17 |
4 |
OE |
$5.00 |
$5,000 |
D/D |
1,000 |
469,815 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-17 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
74,198 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-24 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
469,815 |
2.37 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-02-24 |
4 |
B |
$0.00 |
$63,932 |
I/I |
20,000 |
2,970,372 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-03-03 |
4 |
OE |
$0.00 |
$87,000 |
I/I |
17,400 |
94,198 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-03-03 |
4 |
OE |
$5.00 |
$25,000 |
D/D |
5,000 |
474,815 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2005-03-18 |
4 |
OE |
$5.00 |
$500,000 |
D/D |
98,000 |
572,815 |
|
- |
|
140 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
